| Industry
Industry name |
Pharmaceuticals |
| Variance
Full Year Net Profit Variance |
-5 |
| Equity
Latest Equity |
13.23 |
| Face Value
Latest Face Value |
8 |
| Reserves
Total Reserve |
592.12 |
| Dividend
Full Year Dividend % |
300 |
| Sales Turnover
Full Year Net Sales |
707.52 |
| Net Profit
Full Year Net Profit |
109.67 |
| Full Year CPS
Full Year Cash Per Share |
79.3 |
| Earning Per Share
Full Year Earning Per Share |
66.3 |
| Quarter CPS
Latest quarter Cash Per Share |
0 |
| Latest Quarter Date
Latest Quarter Yrc |
Mar 1, 2026 |
| Latest Quarter Sales
Latest Quarter Net Sales |
176.89 |
| Previous EPS
Previous earnings per share |
0 |
| Book Value
Book value |
366 |
| Networth
Full Year Return on Networth |
20.28 |
| Price/Book Value
Price to Book value |
6.715847 |
| Yearly PE ratio
Full Year Price to Earning per share |
37.1 |
| Yearly PC ratio
Full Year Price to Cash Per Share |
31 |
| Bse value
BSE Value in lakhs |
101.9 |
| Nse value
NSE Value in lakhs |
2058.85 |
| High
52 week high |
2690 |
| Low
52 week low |
1731 |
| Price
NSE Current market price |
2452 |
| CPM
Current market price |
2458 |
| Market cap
BSE / NSE Market Cap |
4065.7 |
| Net profit
Latest Quarter Net Profit |
29.08 |
| Net profit variance
Latest Quarter Net Profit variance |
34 |
| Result year
Trailing latest month |
Mar 1, 2026 |
| TTM Sales
Trailing Twelve 12 month Net Sales |
0 |
| TTM OP
Trailing Twelve 12 month Operating Profit |
0 |
| TTM OPM
Trailing Twelve 12 month Operating Profit Margin |
0 |
| TTM GP
Trailing Twelve 12 month Gross Profit |
175.68 |
| TTM GPM
Trailing Twelve 12 month Gross Profit Margin |
24.83 |
| TTM NP
Trailing Twelve 12 month Net Profit |
0 |
| TTM NPV
Trailing Twelve 12 month Net Profit Variane |
-5.11 |
| TTM EPS
Trailing Twelve 12 month EPS |
66.31 |
| TTM PE
Trailing Twelve 12 month PE |
37.07 |
| TTM CPS
Trailing Twelve 12 month CPS |
0 |
| Month CPS
Month Cash Per Share |
0 |
| TTM Depreciation
Trailing Twelve 12 month Depreciation |
0 |
| Equity
Latest Equity |
13.23 |
| LTP
Latest Price (BSE/NSE) |
2458 |
| Gross block
Latest Gross Block |
321.1 |
| Loans
Total loans |
0 |
| Advances
Latest Advances for Banks |
0 |
| Net profit asset
Latest Assets |
0 |
| Year OPM
Full Year Operating Profit Margin |
16.9 |
| Year GPM
Full Year Gross Profit Margin |
23.8 |
| Quarter OPM
Latest quater Operation Profit Margin |
17.9 |
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| + Sales | 165 | 172 | 173 | 143 | 169 | 182 | 180 | 177 |
| YOY Sales Growth % | 12% | 12% | 12% | 13% | 2% | 5% | 4% | 24% |
| Gross Sales | 165 | 172 | 173 | 143 | 169 | 182 | 180 | 177 |
| + Expenses | 126 | 154 | 124 | 118 | 125 | 143 | 149 | 144 |
| Material Cost % | 21% | 8% | 16% | 18% | 22% | 21% | 27% | 20% |
| Raw Material Cost | 32 | 21 | 30 | 27 | 32 | 33 | 35 | 36 |
| Change in Inventory | 2 | -7 | -3 | -1 | 5 | 5 | 14 | -2 |
| Manufacturing Cost % | 23% | 39% | 22% | 26% | 19% | 22% | 27% | 27% |
| Employee Cost % | 20% | 19% | 17% | 22% | 20% | 20% | 20% | 21% |
| Other Cost % | 12% | 23% | 17% | 16% | 14% | 16% | 9% | 15% |
| Raw Materials % | 20% | 12% | 17% | 19% | 19% | 18% | 19% | 21% |
| Purchase of Finished Goods % | 15% | 15% | 13% | 15% | 20% | 21% | 24% | 13% |
| Stock Adjustments % | -1% | 4% | 2% | 0% | -3% | -3% | -8% | 1% |
| Other Manufacturing Expenses % | 23% | 39% | 22% | 26% | 19% | 22% | 27% | 27% |
| Operating Profit | 39 | 19 | 49 | 25 | 44 | 39 | 31 | 33 |
| OPM % | 24% | 11% | 28% | 18% | 26% | 21% | 17% | 19% |
| + Other Income | 2 | 2 | 3 | 115 | -3 | 16 | 3 | 14 |
| Miscellaneous Income | 2 | 2 | 3 | 115 | -3 | 16 | 3 | 14 |
| Exceptional Income | 0 | 0 | 0 | 110 | 8 | 11 | 0 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 |
| Profit before tax | 36 | 15 | 47 | 135 | 35 | 49 | 29 | 40 |
| + Tax % | 26% | 72% | 26% | 13% | 26% | 25% | 24% | 26% |
| Current Tax | 10 | 11 | 12 | 17 | 9 | 12 | 7 | 7 |
| Deferred Tax | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 3 |
| + Net Profit | 27 | 4 | 35 | 117 | 26 | 37 | 22 | 30 |
| Extraordinary Income / Expense | 0 | -27 | 0 | 110 | 0 | 11 | -8 | 1 |
| Exceptional Item | 0 | -27 | 0 | 110 | 0 | 11 | -8 | 1 |
| Net Profit After Minority Interest | 35 | 117 | 26 | 37 | 22 | 30 | ||
| EPS in Rs | 21.12 | 70.96 | 15.90 | 22.28 | 13.38 | 18.08 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Sales | 307 | 347 | 330 | 376 | 389 | 440 | 513 | 582 | 653 | 708 |
| Sales Growth % | 13% | -5% | 14% | 4% | 13% | 17% | 14% | 12% | 8% | |
| Gross Sales | 280 | 341 | 330 | 376 | 389 | 440 | 513 | 582 | 653 | 708 |
| Excise Duty | 13 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Expenses | 279 | 310 | 297 | 322 | 319 | 354 | 410 | 454 | 510 | 581 |
| Material Cost % | 33% | 33% | 33% | 34% | 34% | 32% | 33% | 32% | 33% | 36% |
| Raw Material Cost | 112 | 121 | 96 | 134 | 136 | 167 | 178 | 182 | 205 | 274 |
| Change in Inventory | -10 | -7 | 14 | -6 | -5 | -25 | -7 | 3 | 9 | -22 |
| Manufacturing Cost % | 8% | 8% | 8% | 7% | 8% | 8% | 7% | 7% | 7% | 7% |
| Employee Cost % | 25% | 26% | 27% | 24% | 24% | 23% | 23% | 23% | 19% | 20% |
| Other Cost % | 25% | 22% | 22% | 21% | 16% | 17% | 17% | 17% | 19% | 20% |
| Raw Materials % | 37% | 35% | 29% | 36% | 35% | 38% | 35% | 31% | 31% | 39% |
| Purchase of Finished Goods % | 18% | 14% | 14% | 16% | 13% | 18% | 18% | 11% | 15% | 20% |
| Stock Adjustments % | 3% | 2% | -4% | 2% | 1% | 6% | 1% | -0% | -1% | 3% |
| Power & Fuel % | 3% | 3% | 3% | 3% | 3% | 3% | 3% | 2% | 3% | 3% |
| Other Manufacturing Expenses % | 5% | 5% | 4% | 4% | 5% | 5% | 4% | 4% | 4% | 4% |
| Selling & Administration % | 18% | 18% | 18% | 15% | 15% | 16% | 14% | 14% | 15% | 14% |
| Miscellaneous Expenses % | 3% | 3% | 3% | 5% | 1% | 1% | 2% | 3% | 4% | 6% |
| Operating Profit | 28 | 38 | 34 | 54 | 70 | 86 | 103 | 128 | 143 | 126 |
| OPM % | 9% | 11% | 10% | 14% | 18% | 20% | 20% | 22% | 22% | 18% |
| + Other Income | 10 | 1 | 1 | 1 | 1 | 3 | 5 | 7 | 112 | 50 |
| Miscellaneous Income | 10 | 1 | 1 | 1 | 1 | 3 | 5 | 7 | 123 | 29 |
| Exceptional Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 110 | 21 |
| Interest | 4 | 5 | 5 | 3 | 2 | 1 | 1 | 1 | 2 | 2 |
| Depreciation | 11 | 14 | 15 | 16 | 16 | 16 | 16 | 17 | 21 | 21 |
| Profit before tax | 24 | 20 | 15 | 36 | 54 | 73 | 92 | 118 | 233 | 154 |
| + Tax % | 10% | 34% | 28% | 20% | 25% | 30% | 26% | 26% | 21% | 25% |
| Current Tax | 5 | 4 | 3 | 10 | 17 | 23 | 24 | 33 | 50 | 35 |
| Deferred Tax | -2 | 3 | 1 | -3 | -4 | -1 | 0 | -2 | 0 | 4 |
| + Net Profit | 21 | 13 | 11 | 29 | 40 | 51 | 68 | 88 | 183 | 115 |
| Profit Growth % | -36% | -20% | 168% | 38% | 29% | 31% | 30% | 109% | -37% | |
| Extraordinary Income / Expense | 0 | 0 | 0 | -5 | 0 | 0 | 0 | 0 | 83 | 4 |
| Exceptional Item | 0 | 0 | 0 | -5 | 0 | 0 | 0 | 0 | 83 | 4 |
| Net Profit After Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 183 | 115 |
| EPS in Rs | 110.80 | 69.64 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 134 | 142 | 147 | 163 | 203 | 243 | 294 | 362 | 517 | 592 |
| + Borrowings | 45 | 54 | 37 | 12 | 2 | 1 | 0 | 0 | 0 | 20 |
| Secured Borrowings | 44 | 50 | 14 | 7 | 0 | 0 | 0 | 0 | 0 | 20 |
| Unsecured Borrowings | 0 | 4 | 23 | 5 | 2 | 1 | 0 | 0 | 0 | 0 |
| Deferred Credit | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Other Liabilities | 55 | 82 | 54 | 78 | 85 | 88 | 112 | 138 | 127 | 168 |
| Current Liabilities | 59 | 89 | 61 | 82 | 87 | 87 | 109 | 136 | 126 | 165 |
| Provisions | 11 | 12 | 10 | 13 | 14 | 15 | 12 | 15 | 16 | 30 |
| Other liability items | 5 | 6 | 6 | 6 | 7 | 6 | 7 | 7 | 7 | 11 |
| Total Liabilities | 247 | 291 | 251 | 267 | 303 | 345 | 419 | 513 | 658 | 793 |
| + Fixed Assets | 137 | 131 | 128 | 123 | 113 | 104 | 124 | 114 | 172 | 197 |
| Gross Block | 142 | 151 | 163 | 174 | 180 | 186 | 220 | 222 | 276 | 321 |
| Accumulated Depreciation | 6 | 20 | 35 | 51 | 67 | 83 | 96 | 108 | 104 | 125 |
| CWIP | 2 | 9 | 17 | 10 | 12 | 31 | 25 | 96 | 16 | 23 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 58 | 91 | 127 | 85 |
| + Other Assets | 108 | 152 | 106 | 134 | 178 | 210 | 211 | 212 | 343 | 488 |
| Inventories | 46 | 54 | 41 | 47 | 58 | 83 | 95 | 101 | 93 | 124 |
| Trade receivables | 39 | 68 | 39 | 63 | 57 | 33 | 37 | 49 | 87 | 117 |
| Cash Equivalents | 2 | 1 | 1 | 1 | 41 | 70 | 57 | 36 | 140 | 192 |
| Loans n Advances | 29 | 40 | 36 | 29 | 28 | 26 | 21 | 27 | 27 | 52 |
| Other asset items | -8 | -11 | -10 | -6 | -7 | -3 | 1 | -2 | -3 | 5 |
| Total Assets | 247 | 291 | 251 | 267 | 303 | 345 | 419 | 513 | 658 | 793 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Cash from Operating Activity | 7 | 15 | 46 | 50 | 58 | 65 | 91 | 94 | 78 | 57 |
| Profit from Operations | 157 | 137 | ||||||||
| Working Capital Changes | -26 | -43 | ||||||||
| Profit Before Tax & Extraordinary Items | 23 | 20 | 15 | 36 | 54 | 73 | 92 | 118 | 233 | 154 |
| Depreciation | 12 | 14 | 15 | 16 | 16 | 16 | 16 | 17 | 21 | 21 |
| Interest (Net) | 2 | 4 | 4 | 2 | 0 | -1 | -2 | -1 | -3 | -9 |
| Profit / Loss on Sale of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | -1 | 0 |
| Profit / Loss on Sale of Investments | 0 | 0 | 0 | 0 | 0 | -1 | 0 | -1 | -2 | -3 |
| Provisions & Write-offs (Net) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3 | -3 | 10 |
| Profit / Loss in Forex | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | -1 |
| Receivables | -9 | -28 | 29 | -24 | 6 | 25 | -5 | -14 | -36 | -30 |
| Inventories | -9 | -8 | 13 | -6 | -12 | -25 | -12 | -6 | 6 | -31 |
| Trade Payables | -2 | 24 | -27 | 19 | 3 | -2 | 19 | 6 | 10 | 18 |
| Loans & Advances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Direct Taxes Paid | -4 | -4 | -4 | -6 | -8 | -19 | -25 | -29 | -53 | -37 |
| + Cash from Investing Activity | -30 | -16 | -19 | -11 | -8 | -35 | -106 | -79 | -42 | 86 |
| Purchase of Fixed Assets | -56 | -15 | -20 | -11 | -9 | -24 | -33 | -69 | -36 | -65 |
| Sale of Fixed Assets | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 109 | 0 |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -57 | -44 | -77 | -10 |
| Sale of Investments | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 18 | 48 | 58 |
| Interest Received | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 1 | 3 | 10 |
| Others | 25 | 0 | 0 | 0 | 0 | -13 | -19 | 14 | -90 | 93 |
| + Cash from Financing Activity | 23 | 0 | -27 | -39 | -10 | -14 | -17 | -20 | -27 | -21 |
| Proceeds from Issue of Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Proceeds from Other Long-Term Borrowings | 21 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 20 |
| Proceeds from Short-Term Borrowings | 6 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Repayment of Long-Term Borrowings | 0 | -5 | -12 | 0 | -4 | 0 | 0 | 0 | 0 | 0 |
| Repayment of Short-Term Borrowings | 0 | 0 | -9 | -24 | -5 | 0 | 0 | 0 | 0 | 0 |
| Repayment of Financial Liabilities | 0 | 0 | 0 | -1 | -1 | -1 | -1 | 0 | 0 | 0 |
| Dividend Paid | 0 | -6 | -5 | -13 | 0 | -12 | -16 | -20 | -26 | -40 |
| Interest Paid | -1 | -1 | ||||||||
| Net Cash Flow | 1 | -1 | 0 | 0 | 40 | 17 | -32 | -5 | 9 | 122 |